Focus on Neurology
Jill Debolt
aggressive therapy, AIN, Anderson, Anderson serve, being part, blocker, busy neurology practice, certified multidisciplinary MS center, certified principal investigator, challenge of complex neurology case, chronic neurological condition, clinical trial, cognitive rehab, complex neurology case, cutting-edge of the new treatment option, demyelization, demyelization of the nerve fiber sheath, dopamine, early referral, eastern half of Kentucky, Everman, game changer, game-changing, game-changing treatment, general neurology practice, Gregory Anderson, health neurology, healthcare, healthcare population, high enroll site, importance of early referral, independent AIN clinical research division, investigator, Kentucky, Kentucky native, KentuckyOne, KentuckyOne health, KentuckyOne health network, KentuckyOne health neurology associate, KentuckyOne neurology associate, Lemtrada, Lexington neurologist, medical director, medication, migraine, MS, MS center, multiple sclerosis, Nancy heckler, nerve fiber sheath, neurologist, neurology, neurology case, neurology practice, neurology research center, neurology residency, new onset weakness, new treatment, Nicole Everman, nurse navigator, onset weakness, Parkinson, Parkinson 's disease, physician, physician involvement, physician leadership, physician market leader, quality of life, recent FDA approval, recent FDA approval of Lemtrada, recent personal goal, research center, research division, residency, sclerosis, suite, support patient, therapy, transformation of healthcare, treatment of Ms., treatment option, university of Kentucky, wellness approach
LEXINGTON Neurologists have much hope to offer patients with chronic neurological conditions by using new and aggressive therapies that significantly
Read more